Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2007
10/10/2007CN100341853C Taxane with alkyl subtituted lateral chain and medicinal composition containing said compound
10/10/2007CN100341831C Long chain hydrocarbyl group substituted phenol chemical and its preparation method and uses
10/10/2007CN100341582C Medicine of vasoactive peptide derivative containing SN3 ligand and its making method
10/10/2007CN100341572C Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
10/10/2007CN100341571C Medicine for treating tumor and use thereof
10/10/2007CN100341527C Chinese medicine for treating tumor and its preparation method
10/10/2007CN100341524C Minari extract for preventing the induction and metast asis of cancer by carcinogens contained in cigarette smoke, fermented foods or alcoholic drinks
10/10/2007CN100341519C Medical use of engrafted nanometer carbon
10/10/2007CN100341505C Methods of administering epothilone analogs for treatment of cancer
10/10/2007CN100341485C Anticancer compositions
10/09/2007US7279567 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
10/09/2007US7279502 Such as prostate cancer, prostatitis and benign prostatic hyperplasia; ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane
10/09/2007US7279499 Substituted benzopyrans as selective estrogen receptor-beta agonists
10/09/2007US7279489 Compounds and methods for modulation of estrogen receptors
10/09/2007US7279485 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
10/09/2007US7279482 Such as 6-(2-hydroxy-3-chloroxybenzylamino)purine, 6-(2-hydroxy-4-chlorobenzylamino)purine; agriculture; cloning; immunostimulation
10/09/2007US7279480 Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation
10/09/2007US7279478 Cathepsin cysteine protease inhibitors
10/09/2007US7279477 Cardiovascular disease, diabetes, acidosis, cancer, obesity; such as 1-butyl-3,3-dimethyl-1-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl -ethyl)-phenyl)-thiourea
10/09/2007US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device
10/09/2007US7279473 Administered singly or in combination with a second antineoplastic agent; cyclin-dependent kinase inhibitors, antiproliferative agents; coupling and cyclization of a 1-aminopyridazinium salt with a 2-alkylthio-4-alkynyl pyrimidine compound
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279467 Benzothiazole-and benzoxazole-4, 7-dione derivatives and their use as dcd25 phosphatase inhibitors
10/09/2007US7279466 Anticarcinogenic agents
10/09/2007US7279464 For immunizing a mammal against cancer cells that present a carcinoembryonic antigen (CEA)
10/09/2007US7279331 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders
10/09/2007US7279324 Nucleic acid encoding G-protein coupled receptor with modified DRY motif
10/09/2007US7279318 Reacting the elements such as viruses and other micro-organisms with a synthetic hydrophilic multivalent polymer with a backbone based upon monomer units of N-2-hydroxypropylmethacrylamide, N-(2-Hydroxy ethyl)-L-Glutamine, ethyleneglycol-oligopeptide or dextran monomers and multiple reactive groups
10/09/2007US7279307 Determining the risk of metastasis of a breast or colon tumor, which involve determining whether a tissue sample from a tumor expresses a polypeptide encoded by a gene SEQ ID NOS:1-18
10/09/2007US7279299 Contacting a candidate molecule with a polypeptide, Polypeptide retains the ability to dephosphorylate an activated MAP-kinase; detecting the presence or absence of binding of the candidate molecule to the polypeptide, and determining whether the candidate molecule interacts with the DSP-10 polypeptide
10/09/2007US7279179 Liposome-entrapped topoisomerase inhibitors
10/09/2007CA2195428C Water-soluble esters of camptothecin compounds
10/09/2007CA2161857C Oxazolidinone derivatives as adhesion receptor antagonists
10/05/2007CA2646021A1 O-glycans in the treatment of inflammatory bowel disease and cancers
10/04/2007WO2007112347A1 Dipeptidyl peptidase inhibitors
10/04/2007WO2007112121A2 Tetracycline compounds and methods of treatment
10/04/2007WO2007112098A2 Uses of diphenyl/diphenylamine carboxylic acids
10/04/2007WO2007111421A1 A method for treating tumor using irradiated tumor cell expressing human hepatitis b surface antigen and a pharmaceutical composition comprising the tumor cell
10/04/2007WO2007111350A1 Agent for inhibition of angiogenesis or mesenchymal-type or amoeboid-type invasion of cancer cell
10/04/2007WO2007111321A1 Method of analyzing sulfated polysaccharide or sulfated oligosaccharide, pharmaceutical composition and drug containing sulfated polysaccharide or sulfated oligosaccharide, method of producing the pharmaceutical composition and the drug and method of treating, diagnosing, symptom-relieving and preventing disease
10/04/2007WO2007111275A1 Method for inhibiting signal transduction, signal transduction inhibitor to be used therein and use thereof
10/04/2007WO2007111227A1 Acylaminopiperidine compound
10/04/2007WO2007111212A1 Triazolone derivative
10/04/2007WO2007111211A1 Polymer conjugate of taxane
10/04/2007WO2007111038A1 Aggrecanase production inhibitor
10/04/2007WO2007110977A1 Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical
10/04/2007WO2007110745A1 Combination therapy for treatment of cancer
10/04/2007WO2007110623A2 Screening method
10/04/2007WO2007110344A1 Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
10/04/2007WO2007110339A1 Anti-igf-1r human monoclonal antibody formulation
10/04/2007WO2007110243A1 Medicament, cosmetic or food product comprising an indol compound, the use thereof and the method of isolation thereof from sauerkraut
10/04/2007WO2007110241A1 Plant extracts, plant components and the uses thereof
10/04/2007WO2007110214A1 12-aza-ep0thil0nes, process for their preparation and their use as antiproliferative agents
10/04/2007WO2007110210A2 Angiomotin sirna molecules and uses thereof
10/04/2007WO2007110109A1 Novel method
10/04/2007WO2007110003A2 Micellar carriers for drugs with anti-cancer activity
10/04/2007WO2007109908A1 Therapeutic yb-1 phosphorylation decoys
10/04/2007WO2007109853A1 Inorganic selenium for treatment of benign tumors
10/04/2007WO2007109852A1 Selenium for treatment of cancer
10/04/2007WO2007109825A1 Method for treating stage iv melanoma
10/04/2007WO2007084672A3 Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues
10/04/2007WO2007079999A3 Pyridopyrazine derivatives and use thereof as modulators of the signal transduction paths
10/04/2007WO2007071422A3 Pharmaceutical antibody compositions with resistance to soluble cea
10/04/2007WO2007068485A3 Biological materials and uses thereof
10/04/2007WO2007066181A3 Methods of preparing a vegf-r inhibitor
10/04/2007WO2007063384A3 Pyrimidine derivatives for the treatment of abnormal cell growth
10/04/2007WO2007054831A3 Inhibitors of vegf receptor and hgf receptor signaling
10/04/2007WO2007054100A3 Lna nucleoside phosphoramidates
10/04/2007WO2007049137A3 Canola extracts containing high levels of sinapic acid
10/04/2007WO2007045389A3 Method for discovering inhibitors of the epstein-barr virus-induced gene 3 (ebi3) and derivatives thereof for the treatment of metastasizing tumors and allergic asthma
10/04/2007WO2007042289A3 Nanobodies™ and polypeptides against egfr and igf-ir
10/04/2007WO2007038637A3 Human monoclonal antibodies to cd70
10/04/2007WO2007035620A3 Carbazole derivatives
10/04/2007WO2007035489A3 Methods of treating or preventing cancer using pyridine carboxaldehyde pyridine thiosemicarbazone radiosensitizing agents
10/04/2007WO2007007207A8 Pharmaceutical compositions of 3, 5 -bis (arylidene) -4 -piperidones and analogues there of for modulating cell proliferation
10/04/2007WO2006094810A3 Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch
10/04/2007WO2005032462A3 Glucocerebroside treatment of disease
10/04/2007WO2004071457A3 Improved heat shock protein-based vaccines and immunotherapies
10/04/2007US20070232798 Process For The Synthesis Of 2'-O-Substituted Pyrimidines And Oligomeric Compounds Therefrom
10/04/2007US20070232696 Valproic acid and derivatives thereof as histone deacetylase inhibitors
10/04/2007US20070232692 Method of Treating Cancer Using Dithiocarbamate Derivatives
10/04/2007US20070232643 Quinoline derivative, e.g. 2[4-(7-chloroquinolin-2-yloxy)phenoxy]propionic acid sodium salt; anticarcinogenic, antitumor agent; colon, breast, melanoma, pancreatic cancer or adenocarcinoma; melanoma, or leukemia; based on herbicides
10/04/2007US20070232639 Camptothecin Derivatives Conjugated in Position 20 with Integrin Antagonists
10/04/2007US20070232613 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/04/2007US20070232611 Amide Derivatives of 3-Phenyl-Dihydropyrimido[4,5-D]Pyrimidinones, Their Manufacture and Use as Pharmaceutical Agents
10/04/2007US20070232602 Thiophene Derivatives, Their Manufacture and Use as Pharmaceutical Agents
10/04/2007US20070232601 Vla-4 Inhibitor
10/04/2007US20070232592 Therapeutic Compositions Containing at Least one Pyrrolobenzodiazepine Derivative and Fludarabine
10/04/2007US20070232586 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof
10/04/2007US20070232574 2-Oxothiazolidine 4-Carboxylic acid compounds for promoting desquamation of the skin
10/04/2007US20070232557 Methods and compositions for inhibiting the function of polynucleotide sequences
10/04/2007US20070232536 Pharmaceutical compositions containing plasma protein
10/04/2007US20070231863 Expression vector comprising nucleotide sequences coding homeobox gene for use in identifying modulators for treatment and prevention of nervous system and seizure disorders
10/04/2007US20070231830 Using competitive binding assays to identify peptide modulators for signal transduction
10/04/2007US20070231418 Emulsion containing a plant extract, method for producing said emulsion and for obtaining said plant extract
10/04/2007US20070231408 Colloidal metal compositions and methods
10/04/2007US20070231352 Mucoadhesive thermoresponsive medicament-carrier composition
10/04/2007US20070231325 Prospective identification and characterization of breast cancer stem cells
10/04/2007US20070231309 Cell populations which co-express CD49c and CD90
10/04/2007US20070231267 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
1 ... 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 ... 2211